US$ 25.01
nexplanon and semaglutide Buy (20 mg) | Order Research Peptides Can I Take Ozempic, Wegovy,
Description
At 1 year after cessation, an estimated 40.2% of the on-treatment weight loss remained

Three of our portfolio companies are helping define what that looks like: FlyteHealth, OpenLoop, and Tenovi, an Inc
Explore GLP-1 benefits regarding weight loss, blood sugar, and heart health
This is one great stock$1.20 $5 in 4 months from trough to peak this year-but one odd company

Current annual therapy cost: ~1.51.7 lakh per patient At 5060% lower pricing: ~70,00085,000 per year Savings of nearly 80,0001,00,000 per patient annually Now consider scale: 100,000 patients 75,000 750 crore annual market 500,000 patients (just ~0.5% of high-risk obese population) 3,750 crore opportunity And thats only drug revenue

Coverage of Lillys obesity medications is expanding in the near future
